These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34337013)

  • 1. Study of the G Protein Nucleolar 2 Value in Liver Hepatocellular Carcinoma Treatment and Prognosis.
    Dong Y; Cai Q; Fu L; Liu H; Ma M; Wu X
    Biomed Res Int; 2021; 2021():4873678. PubMed ID: 34337013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOP16 promotes hepatocellular carcinoma progression and triggers EMT through the Keap1-Nrf2 signaling pathway.
    Mu S; Tian Q; Shen L
    Technol Health Care; 2024; 32(4):2463-2483. PubMed ID: 38251077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potential crucial genes associated with the pathogenesis and prognosis of liver hepatocellular carcinoma.
    Shi L; Shang X; Nie K; Lin Z; Zheng M; Wang M; Yuan H; Zhu Z
    J Clin Pathol; 2021 Aug; 74(8):504-512. PubMed ID: 33004423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Single-cell and Transcriptome Sequencing Analyses Identified PREX1 as an Immune-related Prognostic Biomarker for Liver Hepatocellular Carcinoma.
    Yang J; Fan LY; Shi KY
    Int J Med Sci; 2024; 21(8):1559-1574. PubMed ID: 38903921
    [No Abstract]   [Full Text] [Related]  

  • 5. SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma.
    Chang Q; Xu Y; Wang J; Jing H; Rao L; Tang W; Zhang Z; Wu X
    Comput Math Methods Med; 2021; 2021():8556888. PubMed ID: 34819993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comprehensive roles of lncRNA FAM99A/FAM99B in hepatocellular carcinoma: Expressions, regulatory mechanisms and functional pathway analysis.
    Jin H; Li Y; Qin S; Li Q; Mao Y; Zhao L
    Life Sci; 2024 Jul; 349():122710. PubMed ID: 38740325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation Mitochondrial Carrier 1 (MTCH1) Is Associated with Cell Proliferation, Invasion, and Migration of Liver Hepatocellular Carcinoma.
    Chen G; Mo S; Yuan D
    Biomed Res Int; 2021; 2021():9911784. PubMed ID: 34195286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the role of CDCA4 in liver hepatocellular carcinoma using bioinformatics analysis and experiments.
    Liang C; Long K; Zheng W; Zhong R; Li Z; Zhu S; Gu S; Zhu C; Yang Y
    Medicine (Baltimore); 2024 May; 103(18):e38028. PubMed ID: 38701314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3-mediated m6A methylation of ASPM drives hepatocellular carcinoma cells growth and metastasis.
    Wang A; Chen X; Li D; Yang L; Jiang J
    J Clin Lab Anal; 2021 Sep; 35(9):e23931. PubMed ID: 34398984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-SMC condensin I complex subunit H enhances proliferation, migration, and invasion of hepatocellular carcinoma.
    Sun C; Huang S; Wang H; Xie R; Zhang L; Zhou Q; He X; Ju W
    Mol Carcinog; 2019 Dec; 58(12):2266-2275. PubMed ID: 31523845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SEMA3F Promotes Liver Hepatocellular Carcinoma Metastasis by Activating Focal Adhesion Pathway.
    Ye K; Ouyang X; Wang Z; Yao L; Zhang G
    DNA Cell Biol; 2020 Mar; 39(3):474-483. PubMed ID: 31968181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein Regulator of Cytokinesis 1 (PRC1) Upregulation Promotes Immune Suppression in Liver Hepatocellular Carcinoma.
    Zhang C; Xu H; Sui X; Wu T; Chen B; Wang S; Wang X
    J Immunol Res; 2022; 2022():7073472. PubMed ID: 35983074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testis-specific protein, Y-linked 1 activates PI3K/AKT and RAS signaling pathways through suppressing IGFBP3 expression during tumor progression.
    Tu W; Yang B; Leng X; Pei X; Xu J; Liu M; Dong Q; Tao D; Lu Y; Liu Y; Yang Y
    Cancer Sci; 2019 May; 110(5):1573-1586. PubMed ID: 30815935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpressed Histocompatibility Minor 13 was Associated with Liver Hepatocellular Carcinoma Progression and Prognosis.
    Zong RQ; Zhang HY; Li XY; Li YR; Chen Y
    Genet Res (Camb); 2022; 2022():7067743. PubMed ID: 36262249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GTSE1, CDC20, PCNA, and MCM6 Synergistically Affect Regulations in Cell Cycle and Indicate Poor Prognosis in Liver Cancer.
    Zheng Y; Shi Y; Yu S; Han Y; Kang K; Xu H; Gu H; Sang X; Chen Y; Wang J
    Anal Cell Pathol (Amst); 2019; 2019():1038069. PubMed ID: 32082966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRIF1 overexpression facilitates tumor growth and metastasis through inducing ROS/NFκB pathway in hepatocellular carcinoma.
    Chang H; Li J; Qu K; Wan Y; Liu S; Zheng W; Zhang Z; Liu C
    Cell Death Dis; 2020 May; 11(5):332. PubMed ID: 32382077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
    Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
    Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma.
    Dai B; Ruan B; Wu J; Wang J; Shang R; Sun W; Li X; Dou K; Wang D; Li Y
    Int J Clin Exp Pathol; 2014; 7(9):5645-54. PubMed ID: 25337205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma.
    Mo Z; Liu D; Rong D; Zhang S
    Front Immunol; 2021; 12():611058. PubMed ID: 33679749
    [No Abstract]   [Full Text] [Related]  

  • 20. Gene signatures and prognostic values of m1A-related regulatory genes in hepatocellular carcinoma.
    Shi Q; Xue C; Yuan X; He Y; Yu Z
    Sci Rep; 2020 Sep; 10(1):15083. PubMed ID: 32934298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.